Octanoic acid

CAS No. 95809-78-2

Octanoic acid( CPI-613 )

Catalog No. M16844 CAS No. 95809-78-2

CPI-613, a lipoate analog, inhibits mitochondrial enzymes pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase, disrupts tumor cell mitochondrial metabolism.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 49 In Stock
10MG 58 In Stock
25MG 101 In Stock
50MG 129 In Stock
100MG 170 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Octanoic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    CPI-613, a lipoate analog, inhibits mitochondrial enzymes pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase, disrupts tumor cell mitochondrial metabolism.
  • Description
    CPI-613, a lipoate analog, inhibits mitochondrial enzymes pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase, disrupts tumor cell mitochondrial metabolism. Phase 2.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    CPI-613
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Dehydrogenase
  • Recptor
    α-ketoglutarate dehydrogenase| PDH
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    95809-78-2
  • Formula Weight
    388.59
  • Molecular Formula
    C22H28O2S2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:78 mg/mL (200.72 mM); Ethanol:78 mg/mL (200.72 mM); Water:<1 mg/mL (<1 mM)
  • SMILES
    O=C(O)CCCCC(SCC1=CC=CC=C1)CCSCC2=CC=CC=C2
  • Chemical Name
    6,8-bis(benzylthio)octanoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Zachar Z, et al. J Mol Med (Berl). 2011, 89(11), 1137-1148.
molnova catalog
related products
  • G-749

    G-749, a new-type FLT3 inhibitor, exhibits effective and sustained inhibition of the FLT3 wild type and mutants.

  • Atovaquone

    Atovaquone is a medication used to treat or prevent for pneumocystis pneumonia, toxoplasmosis, malaria, and babesia.

  • ASLAN003

    ASLAN003 is an orally active and potent inhibitor of DHODH (Human Dihydroorotate Dehydrogenase) with antitumor activity. It has the potential to be a first-in-class candidate in AML.